You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 9,505,722


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,505,722
Title:Azepane derivatives and methods of treating hepatitis B infections
Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Inventor(s): Hartman; George D. (Lansdale, PA), Kuduk; Scott (Harleysville, PA)
Assignee: NOVIRA THERAPEUTICS, INC. (Doylestown, PA)
Application Number:14/694,147
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of a Patent: A Detailed Analysis of United States Patent 9,505,722

Introduction

Patents are a crucial component of intellectual property law, providing inventors and innovators with exclusive rights to their inventions. To fully comprehend the significance and implications of a patent, it is essential to delve into its scope, claims, and the broader patent landscape. This article will provide a detailed analysis using the example of United States Patent 9,505,722, although the specific details of this patent are not provided in the sources, we will use general principles to illustrate the process.

What is a Patent?

A patent is a form of intellectual property that grants its owner the exclusive right to make, use, sell, and import an invention for a specified period, typically 20 years from the date of the patent application[1].

The Patent Application Process

To obtain a patent, an applicant must submit a detailed and clear description of the invention, known as the "specification," which must support the patent's "claims." These claims define the scope of the exclusive legal rights granted by the patent. The application is reviewed by patent examiners at the United States Patent and Trademark Office (USPTO) to ensure it meets the requirements of novelty, nonobviousness, and utility[1].

Patentability Requirements

For an invention to be patentable, it must meet several criteria:

  • Usefulness: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge.
  • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[1].

The Role of Claims in a Patent

Claims are the most critical part of a patent application as they define the scope of the invention and the exclusive rights granted to the patent holder. These claims must be clear, concise, and supported by the specification. The claims determine what is protected by the patent and what constitutes infringement[1].

Analyzing the Scope of a Patent

The scope of a patent is determined by its claims. Here are the key steps to analyze the scope:

Claim Construction

Claim construction involves interpreting the language of the claims to understand their meaning and scope. This process is crucial in determining what the patent protects and what might infringe on it[2].

Claim Types

Patents can have different types of claims, such as:

  • Independent Claims: These claims stand alone and define the invention.
  • Dependent Claims: These claims refer back to and further limit the independent claims[1].

Scope Concepts

To analyze the scope effectively, it is helpful to categorize claims by overarching scope concepts. This method, used in patent analytics, allows for filtering, searching, and analyzing large numbers of patent claims concurrently. Tools like ClaimScape® software generate interactive claim charts that help in determining whether a particular scope concept is applicable to a target product or method[3].

Patent Landscape Analysis

Understanding the patent landscape involves identifying which patents and claims are actively protecting your intellectual property and where gaps or opportunities exist.

Claim Coverage Matrix

A Claim Coverage Matrix helps in identifying which patents and claims cover specific technologies. This matrix categorizes patents not only by claims but also by the scope concepts that link claims on similar patents. This approach is particularly useful for large portfolios where tracking individual patents and claims can be cumbersome[3].

Technological Fields

Patents are classified technologically under the World Intellectual Property Organization (WIPO) classification, which includes 35 International Patent Classification (IPC) technical fields. This classification helps in allocating patents geographically and technologically, providing a detailed view of the patent landscape across different fields[4].

Case Study: Analyzing Patent Claims and Scope

Example: United States Patent 9,505,722

While the specific details of this patent are not provided, here is a general approach to analyzing its scope and claims:

Step 1: Review the Specification

Read the detailed description of the invention to understand its components, functionality, and any specific embodiments.

Step 2: Analyze the Claims

Identify the independent and dependent claims. Understand how each claim defines the invention and its scope.

Step 3: Determine Scope Concepts

Categorize the claims by overarching scope concepts to filter and analyze them effectively. Use tools like ClaimScape® software to generate interactive claim charts.

Step 4: Evaluate Prior Art

Consider prior patents, publications, and other state of the art knowledge to assess the novelty and nonobviousness of the invention.

Step 5: Assess Infringement

Determine what actions would constitute infringement of the patent by comparing the claims with potential infringing activities.

Challenges and Considerations

Patent Quality

Poor quality patents, which are unclear or invalid, can breed uncertainty and make investing in innovation riskier. Ensuring that patents meet the standards of patentability is crucial for maintaining the integrity of the patent system[1].

Obviousness and Novelty

Determining whether an invention is obvious or novel involves a thorough analysis of prior art. Cases like Bhagat v. PTO highlight the importance of this analysis, where the court found that the application claims were obvious in light of prior expert studies and disclosures[2].

Inventorship

Correct inventorship is vital for the validity of a patent. Errors in inventorship, especially those made with deceptive intent, can render a patent unenforceable[5].

Key Takeaways

  • Patent Scope: The scope of a patent is defined by its claims, which must be clear, concise, and supported by the specification.
  • Claim Analysis: Analyzing claims involves claim construction, identifying claim types, and categorizing by scope concepts.
  • Patent Landscape: Understanding the patent landscape helps in identifying gaps and opportunities in intellectual property protection.
  • Patent Quality: Ensuring high-quality patents is essential for maintaining the integrity of the patent system.
  • Inventorship: Correct and honest inventorship is crucial for the validity and enforceability of a patent.

FAQs

Q: What is the primary purpose of a patent?

A: The primary purpose of a patent is to grant its owner the exclusive right to make, use, sell, and import an invention for a specified period.

Q: How are patent claims analyzed?

A: Patent claims are analyzed through claim construction, identifying claim types, and categorizing by scope concepts to understand their meaning and scope.

Q: Why is patent quality important?

A: Patent quality is important because unclear or invalid patents can breed uncertainty and make investing in innovation riskier.

Q: What happens if there are errors in inventorship?

A: Errors in inventorship, especially those made with deceptive intent, can render a patent unenforceable.

Q: How is the patent landscape analyzed?

A: The patent landscape is analyzed using tools like Claim Coverage Matrix and categorizing patents by scope concepts to identify gaps and opportunities in intellectual property protection.

Sources

  1. Congressional Research Service, "Patents and Innovation Policy," August 2022.
  2. Court of Appeals for the Federal Circuit, "BHAGAT v. PTO," April 2024.
  3. Schwegman Lundberg & Woessner, "Patent Analytics," accessed 2024.
  4. National Science Foundation, "Invention: U.S. and Comparative Global Trends," January 2020.
  5. Oregon State University, "Determining Inventorship for US Patent Applications," accessed 2024.

More… ↓

⤷  Subscribe

Details for Patent 9,505,722

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc RECOMBIVAX, RECOMBIVAX HB hepatitis b vaccine (recombinant) Injection 101066 July 23, 1986 9,505,722 2034-01-16
Glaxosmithkline Biologicals ENGERIX-B hepatitis b vaccine (recombinant) Injection 103239 August 28, 1989 9,505,722 2034-01-16
Pharmaand Gmbh PEGASYS peginterferon alfa-2a Injection 103964 October 16, 2002 9,505,722 2034-01-16
Pharmaand Gmbh PEGASYS peginterferon alfa-2a Injection 103964 January 07, 2004 9,505,722 2034-01-16
Pharmaand Gmbh PEGASYS peginterferon alfa-2a Injection 103964 September 29, 2011 9,505,722 2034-01-16
Hoffmann-la Roche Inc. PEGASYS COPEGUS COMBINATION PACK peginterferon alfa-2a and ribavirin 125083 June 04, 2004 9,505,722 2034-01-16
Schering Corporation A Subsidiary Of Merck & Co., Inc. PEGINTRON/ REBETOL COMBO PACK peginterferon alfa-2b and ribavirin 125196 June 13, 2008 9,505,722 2034-01-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.